{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:08:21Z","timestamp":1793394501734,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017607","name":"Shenzhen Basic Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbcan.2024.189199","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:00:21Z","timestamp":1729072821000},"page":"189199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Modeling bladder cancer in the laboratory: Insights from patient-derived organoids"],"prefix":"10.1016","volume":"1879","author":[{"given":"Zikai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiren","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2024.189199_bb0005","doi-asserted-by":"crossref","unstructured":"F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 74 (2024) 229\u2013263. doi: https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.bbcan.2024.189199_bb0010","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2024.189199_bb0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1464-410X.2010.09912.x","article-title":"Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience","volume":"108","author":"Yafi","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.bbcan.2024.189199_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cac2.12129","article-title":"Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer","volume":"41","author":"Huang","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbcan.2024.189199_bb0025","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2024.189199_bb0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"KEYNOTE-045 investigators, Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2024.189199_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"BLC2001 study group, Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2024.189199_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189199_bb0050","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00345-018-2369-5","article-title":"Modeling human bladder cancer","volume":"36","author":"Ringuette-Goulet","year":"2018","journal-title":"World. J. Urol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/cells8080889","article-title":"Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models","volume":"8","author":"Okada","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189199_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2013.06.020","article-title":"Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery","volume":"87","author":"Ruggeri","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc3858","article-title":"Modelling bladder cancer in mice: opportunities and challenges","volume":"15","author":"Kobayashi","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189199_bb0070","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.eururo.2006.10.034","article-title":"A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids","volume":"51","author":"Burgu\u00e9s","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.juro.2012.12.106","article-title":"Involvement of heregulin\/HER3 in the primary culture of human urothelial cancer","volume":"190","author":"Okuyama","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/cas.12567","article-title":"High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids","volume":"106","author":"Yoshida","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0085","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41585-020-00389-2","article-title":"Patient-derived tumour models for personalized therapeutics in urological cancers","volume":"18","author":"van de Merbel","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature13863","article-title":"Modelling human development and disease in pluripotent stem-cell-derived gastric organoids","volume":"516","author":"McCracken","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.celrep.2012.12.017","article-title":"Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis","volume":"3","author":"Plaks","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2024.189199_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2019.04.039","article-title":"Organoid technology in cancer precision medicine","volume":"457","author":"Xia","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2024.189199_bb0120","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.1803595116","article-title":"Mouse and human urothelial cancer organoids: a tool for bladder cancer research","volume":"116","author":"Mullenders","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2024.189199_bb0125","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-020-3034-x","article-title":"Creation of bladder assembloids mimicking tissue regeneration and cancer","volume":"588","author":"Kim","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189199_bb0135","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","article-title":"Bladder cancer organoids as a functional system to model different disease stages and therapy response","volume":"14","author":"Minoli","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2024.189199_bb0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2024.189199_bb0145","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/cells12172188","article-title":"A protocol for organoids from the urine of bladder cancer patients","volume":"12","author":"Walz","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189199_bb0150","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbcan.2024.189199_bb0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189199_bb0160","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omto.2022.01.009","article-title":"Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer","volume":"24","author":"Rangsitratkul","year":"2022","journal-title":"Mol. Ther. Oncolyt."},{"key":"10.1016\/j.bbcan.2024.189199_bb0165","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189199_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1248","article-title":"Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro","volume":"10","author":"Yu","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2021.01.025","article-title":"Non-matrigel scaffolds for organoid cultures","volume":"504","author":"Kaur","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2024.189199_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-023-02494-6","article-title":"Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation","volume":"130","author":"Viergever","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189199_bb0185","article-title":"Patient-derived immunocompetent tumor organoids: a platform for chemotherapy evaluation in the context of T-cell recognition","author":"Zhao","year":"2024","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bbcan.2024.189199_bb0190","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.3390\/ijms21217814","article-title":"Investigation of the impact from IL-2, IL-7, and IL-15 on the growth and signaling of activated CD4+ T cells","volume":"21","author":"Coppola","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0195","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab9491","article-title":"Use of inkjet-printed single cells to quantify intratumoral heterogeneity","volume":"12","author":"Yoon","year":"2020","journal-title":"Biofabrication"},{"key":"10.1016\/j.bbcan.2024.189199_bb0200","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.juro.2008.07.023","article-title":"Urine derived cells are a potential source for urological tissue reconstruction","volume":"180","author":"Zhang","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0205","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/stem.1424","article-title":"Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology","volume":"31","author":"Bharadwaj","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2024.189199_bb0210","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.3390\/ijms23116305","article-title":"Urinary tract tumor organoids reveal eminent differences in drug sensitivities when compared to 2-dimensional culture systems","volume":"23","author":"Wei","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0215","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189199_bb0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2024.189199_bb0225","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2024.189199_bb0230","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189199_bb0235","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1038\/s41467-020-19313-8","article-title":"Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients","volume":"11","author":"Kong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2024.189199_bb0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5483\/BMBRep.2022-0200","article-title":"Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers","volume":"56","author":"Seo","year":"2023","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbcan.2024.189199_bb0245","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189199_bb0250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0255","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41698-023-00466-w","article-title":"Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer","volume":"7","author":"Garioni","year":"2023","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0260","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/cells8050470","article-title":"Application of cancer organoid model for drug screening and personalized therapy","volume":"8","author":"Kondo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189199_bb0265","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2024.189199_bb0270","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0275","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189199_bb0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189199_bb0290","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0295","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.3390\/ijms24129854","article-title":"Epigenetic and immunological features of bladder cancer","volume":"24","author":"Gilyazova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0300","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1158\/1078-0432.CCR-10-2017","article-title":"Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer","volume":"17","author":"Dudziec","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189199_bb0305","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/1078-0432.CCR-06-2476","article-title":"Promoter hypermethylation identifies progression risk in bladder cancer","volume":"13","author":"Yates","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189199_bb0310","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1038\/s41388-021-01999-9","article-title":"SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis","volume":"40","author":"Tan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2024.189199_bb0315","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin Chemoresistance by enhancing ac4C-associated DNA repair in bladder Cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189199_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202307933","article-title":"The c-Src\/LIST positive feedback loop sustains tumor progression and chemoresistance","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0325","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.7150\/thno.43811","article-title":"Aurora-a\/SOX8\/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2024.189199_bb0330","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cac2.12274","article-title":"The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells","volume":"42","author":"Wang","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbcan.2024.189199_bb0335","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41419-023-05938-2","article-title":"UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer","volume":"14","author":"Xiao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2024.189199_bb0340","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/annonc\/mdp488","article-title":"Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients","volume":"21","author":"La\u00e9","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0345","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2024.189199_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189199_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302377","article-title":"A HER2-targeted antibody-drug conjugate, RC48-ADC, exerted promising antitumor efficacy and safety with intravesical instillation in preclinical models of bladder cancer","author":"Hong","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0360","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2023.12.057","article-title":"Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy","volume":"366","author":"Zheng","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2024.189199_bb0365","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1038\/s41467-020-19058-4","article-title":"Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids","volume":"11","author":"Schuster","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2024.189199_bb0370","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.aaw7894","article-title":"Organoids-on-a-chip","volume":"364","author":"Park","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189199_bb0375","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1038\/s41598-017-08879-x","article-title":"Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform","volume":"7","author":"Skardal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189199_bb0380","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1039\/C9BM01339C","article-title":"Opposite responses of normal hepatocytes and hepatocellular carcinoma cells to substrate viscoelasticity","volume":"8","author":"Mandal","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbcan.2024.189199_bb0385","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrurol.2015.231","article-title":"Targeted therapies in bladder cancer: an overview of in vivo research","volume":"12","author":"van Kessel","year":"2015","journal-title":"Nat. Rev. Urol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T08:53:17Z","timestamp":1733907197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24001306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0304419X24001306"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189199","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling bladder cancer in the laboratory: Insights from patient-derived organoids","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189199"}}